nodes	percent_of_prediction	percent_of_DWPC	metapath
Metaraminol—Tapentadol—OPRD1—epilepsy syndrome	0.0221	0.156	CrCbGaD
Metaraminol—Edrophonium—BCHE—epilepsy syndrome	0.0216	0.152	CrCbGaD
Metaraminol—Tapentadol—OPRM1—epilepsy syndrome	0.0169	0.119	CrCbGaD
Metaraminol—Levonordefrin—ADRA2A—epilepsy syndrome	0.0104	0.0737	CrCbGaD
Metaraminol—Tapentadol—SLC6A4—epilepsy syndrome	0.00931	0.0657	CrCbGaD
Metaraminol—Tapentadol—CYP2C19—epilepsy syndrome	0.00882	0.0623	CrCbGaD
Metaraminol—Ephedrine—BCHE—epilepsy syndrome	0.00873	0.0616	CrCbGaD
Metaraminol—Phenylpropanolamine—ADRA2A—epilepsy syndrome	0.00801	0.0565	CrCbGaD
Metaraminol—Droxidopa—ADRA2A—epilepsy syndrome	0.00735	0.0519	CrCbGaD
Metaraminol—Pseudoephedrine—ADRA2A—epilepsy syndrome	0.00677	0.0478	CrCbGaD
Metaraminol—Tapentadol—CYP2D6—epilepsy syndrome	0.00654	0.0462	CrCbGaD
Metaraminol—Pseudoephedrine—TNF—epilepsy syndrome	0.00641	0.0453	CrCbGaD
Metaraminol—Pseudoephedrine—SLC6A4—epilepsy syndrome	0.00516	0.0364	CrCbGaD
Metaraminol—Pseudoephedrine—CYP2D6—epilepsy syndrome	0.00363	0.0256	CrCbGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—BDKRB2—epilepsy syndrome	0.0021	0.00245	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—ACKR4—epilepsy syndrome	0.00208	0.00242	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—SSTR5—epilepsy syndrome	0.00207	0.00241	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—SSTR4—epilepsy syndrome	0.00207	0.00241	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—CNR1—epilepsy syndrome	0.00206	0.0024	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—CX3CR1—epilepsy syndrome	0.00202	0.00235	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR7—epilepsy syndrome	0.00201	0.00234	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—CCR10—epilepsy syndrome	0.00198	0.00231	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—BDKRB1—epilepsy syndrome	0.00198	0.0023	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—CX3CL1—epilepsy syndrome	0.00198	0.0023	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—CHRM2—epilepsy syndrome	0.00198	0.0023	CbGpPWpGaD
Metaraminol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—epilepsy syndrome	0.00196	0.00228	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—GABBR1—epilepsy syndrome	0.00192	0.00224	CbGpPWpGaD
Metaraminol—ADRA1A—Calcium Regulation in the Cardiac Cell—PRKCB—epilepsy syndrome	0.00192	0.00223	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	0.00191	0.00223	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	0.00191	0.00223	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—SSTR5—epilepsy syndrome	0.00188	0.00219	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—SSTR4—epilepsy syndrome	0.00188	0.00219	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	0.00187	0.00218	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—HRH3—epilepsy syndrome	0.00184	0.00215	CbGpPWpGaD
Metaraminol—ADRA1A—G alpha (q) signalling events—HTR2A—epilepsy syndrome	0.00182	0.00212	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—OPRM1—epilepsy syndrome	0.00181	0.00211	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CCR10—epilepsy syndrome	0.0018	0.0021	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	0.0018	0.0021	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	0.0018	0.0021	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	0.00177	0.00206	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—GRM2—epilepsy syndrome	0.00173	0.00202	CbGpPWpGaD
Metaraminol—ADRA1A—G alpha (q) signalling events—AGT—epilepsy syndrome	0.00173	0.00201	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	0.00172	0.00201	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—CCR3—epilepsy syndrome	0.00171	0.002	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—NPY—epilepsy syndrome	0.00167	0.00195	CbGpPWpGaD
Metaraminol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—epilepsy syndrome	0.00163	0.0019	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—OXT—epilepsy syndrome	0.00161	0.00188	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—CRH—epilepsy syndrome	0.00161	0.00188	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—CXCL2—epilepsy syndrome	0.00161	0.00188	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—CCL3—epilepsy syndrome	0.00161	0.00188	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—GRM2—epilepsy syndrome	0.00157	0.00183	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—SSTR3—epilepsy syndrome	0.00157	0.00183	CbGpPWpGaD
Metaraminol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—epilepsy syndrome	0.00155	0.0018	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	0.0015	0.00175	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—SSTR1—epilepsy syndrome	0.0015	0.00175	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—CCR8—epilepsy syndrome	0.0015	0.00175	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—CCR9—epilepsy syndrome	0.0015	0.00175	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—NPY2R—epilepsy syndrome	0.0015	0.00175	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—GRM3—epilepsy syndrome	0.00147	0.00172	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—GRM4—epilepsy syndrome	0.00147	0.00172	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—SST—epilepsy syndrome	0.00146	0.0017	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—CCR2—epilepsy syndrome	0.00146	0.0017	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	0.00145	0.00169	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—SSTR2—epilepsy syndrome	0.00145	0.00169	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	0.00144	0.00168	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—ADRA2A—epilepsy syndrome	0.00143	0.00166	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—SSTR3—epilepsy syndrome	0.00142	0.00166	CbGpPWpGaD
Metaraminol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—epilepsy syndrome	0.00142	0.00166	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	0.00141	0.00164	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—PRDM4—epilepsy syndrome	0.0014	0.00164	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.0014	0.00164	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—GRM8—epilepsy syndrome	0.0014	0.00163	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—BDKRB2—epilepsy syndrome	0.00137	0.0016	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—CXCL12—epilepsy syndrome	0.00137	0.0016	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—ARHGEF9—epilepsy syndrome	0.00136	0.00159	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—NPY2R—epilepsy syndrome	0.00136	0.00159	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CCR9—epilepsy syndrome	0.00136	0.00159	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—SSTR1—epilepsy syndrome	0.00136	0.00159	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CCR8—epilepsy syndrome	0.00136	0.00159	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—CNR1—epilepsy syndrome	0.00134	0.00157	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—GRM3—epilepsy syndrome	0.00134	0.00156	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—GRM4—epilepsy syndrome	0.00134	0.00156	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—OPRD1—epilepsy syndrome	0.00133	0.00155	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—SSTR2—epilepsy syndrome	0.00131	0.00153	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—HTR7—epilepsy syndrome	0.00131	0.00153	CbGpPWpGaD
Metaraminol—ADRA1A—AMPK Signaling—AKT1—epilepsy syndrome	0.00129	0.00151	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—PDYN—epilepsy syndrome	0.00128	0.00149	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—GRM1—epilepsy syndrome	0.00128	0.00149	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—CCR7—epilepsy syndrome	0.00128	0.00149	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—CHRM1—epilepsy syndrome	0.00128	0.00149	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—GRM8—epilepsy syndrome	0.00127	0.00148	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	0.00123	0.00144	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—ACKR4—epilepsy syndrome	0.00123	0.00143	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—OPRD1—epilepsy syndrome	0.00121	0.00141	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—GNAO1—epilepsy syndrome	0.00121	0.00141	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	0.00121	0.00141	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—GAL—epilepsy syndrome	0.0012	0.0014	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—CHRM3—epilepsy syndrome	0.00119	0.00138	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—GRM5—epilepsy syndrome	0.00119	0.00138	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CHRM1—epilepsy syndrome	0.00116	0.00135	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—GRM1—epilepsy syndrome	0.00116	0.00135	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CCR7—epilepsy syndrome	0.00116	0.00135	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—PDYN—epilepsy syndrome	0.00116	0.00135	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	0.00114	0.00133	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—BDKRB1—epilepsy syndrome	0.00112	0.0013	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—CHRM2—epilepsy syndrome	0.00112	0.0013	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—SSTR5—epilepsy syndrome	0.00111	0.00129	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—SSTR4—epilepsy syndrome	0.00111	0.00129	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—AVP—epilepsy syndrome	0.0011	0.00129	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—GAL—epilepsy syndrome	0.00109	0.00127	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—GABBR1—epilepsy syndrome	0.00109	0.00127	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CHRM3—epilepsy syndrome	0.00108	0.00126	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—GRM5—epilepsy syndrome	0.00108	0.00126	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CCR10—epilepsy syndrome	0.00106	0.00124	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—HRH3—epilepsy syndrome	0.00104	0.00121	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.00103	0.0012	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—OPRM1—epilepsy syndrome	0.00103	0.00119	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CHRM2—epilepsy syndrome	0.00101	0.00118	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.00101	0.00118	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.00101	0.00118	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—GABBR1—epilepsy syndrome	0.000987	0.00115	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—CCR3—epilepsy syndrome	0.000968	0.00113	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	0.000964	0.00112	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—HRH3—epilepsy syndrome	0.000946	0.0011	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—NPY—epilepsy syndrome	0.000944	0.0011	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	0.000943	0.0011	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—CCR5—epilepsy syndrome	0.000939	0.00109	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—OPRM1—epilepsy syndrome	0.000931	0.00108	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—GRM2—epilepsy syndrome	0.00093	0.00108	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—HTR2A—epilepsy syndrome	0.000919	0.00107	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—CXCL2—epilepsy syndrome	0.00091	0.00106	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—CRH—epilepsy syndrome	0.00091	0.00106	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—OXT—epilepsy syndrome	0.00091	0.00106	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CCR3—epilepsy syndrome	0.000879	0.00102	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—AGT—epilepsy syndrome	0.000872	0.00102	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—NPY—epilepsy syndrome	0.000857	0.000998	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—SSTR3—epilepsy syndrome	0.000841	0.00098	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CCL3—epilepsy syndrome	0.000827	0.000963	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000827	0.000963	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CRH—epilepsy syndrome	0.000827	0.000963	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—OXT—epilepsy syndrome	0.000827	0.000963	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000823	0.000959	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—SST—epilepsy syndrome	0.000823	0.000959	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000823	0.000959	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000806	0.000939	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—SSTR1—epilepsy syndrome	0.000806	0.000939	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—NPY2R—epilepsy syndrome	0.000806	0.000939	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CCR8—epilepsy syndrome	0.000806	0.000939	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CCR9—epilepsy syndrome	0.000806	0.000939	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000806	0.000939	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—GRM4—epilepsy syndrome	0.000791	0.000921	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—GRM3—epilepsy syndrome	0.000791	0.000921	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—DUSP4—epilepsy syndrome	0.000776	0.000904	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—SSTR2—epilepsy syndrome	0.000776	0.000904	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.000774	0.000902	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.000774	0.000902	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—CNR1—epilepsy syndrome	0.00076	0.000885	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000757	0.000882	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—GRM8—epilepsy syndrome	0.000749	0.000873	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—PGF—epilepsy syndrome	0.000749	0.000873	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CCR2—epilepsy syndrome	0.000748	0.000871	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—SST—epilepsy syndrome	0.000748	0.000871	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000741	0.000864	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—POMC—epilepsy syndrome	0.000734	0.000855	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000732	0.000853	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—CCL2—epilepsy syndrome	0.000718	0.000836	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—GNAO1—epilepsy syndrome	0.000715	0.000833	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—OPRD1—epilepsy syndrome	0.000715	0.000833	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000706	0.000823	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000703	0.000819	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000703	0.000819	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CNR1—epilepsy syndrome	0.00069	0.000804	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000688	0.000801	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—GRM1—epilepsy syndrome	0.000685	0.000799	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CCR7—epilepsy syndrome	0.000685	0.000799	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—PDYN—epilepsy syndrome	0.000685	0.000799	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CHRM1—epilepsy syndrome	0.000685	0.000799	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—HTR7—epilepsy syndrome	0.000673	0.000784	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000654	0.000761	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000645	0.000751	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—GAL—epilepsy syndrome	0.000644	0.000751	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—GFAP—epilepsy syndrome	0.000644	0.000751	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—AKT3—epilepsy syndrome	0.000642	0.000747	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—GRM5—epilepsy syndrome	0.000637	0.000742	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CASP2—epilepsy syndrome	0.000637	0.000742	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CHRM3—epilepsy syndrome	0.000637	0.000742	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—AVP—epilepsy syndrome	0.000624	0.000727	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000611	0.000712	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CHRM2—epilepsy syndrome	0.000599	0.000698	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000599	0.000698	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000599	0.000698	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CDC42—epilepsy syndrome	0.000585	0.000682	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—GABBR1—epilepsy syndrome	0.000583	0.000679	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—AVP—epilepsy syndrome	0.000567	0.00066	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—HRH3—epilepsy syndrome	0.000559	0.000651	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—OPRM1—epilepsy syndrome	0.00055	0.000641	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000531	0.000618	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CCR3—epilepsy syndrome	0.000519	0.000605	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.000519	0.000605	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—NPY—epilepsy syndrome	0.000506	0.00059	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000506	0.00059	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—AGT—epilepsy syndrome	0.000493	0.000574	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CCL3—epilepsy syndrome	0.000488	0.000569	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—OXT—epilepsy syndrome	0.000488	0.000569	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CXCL2—epilepsy syndrome	0.000488	0.000569	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CRH—epilepsy syndrome	0.000488	0.000569	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—HSPB1—epilepsy syndrome	0.000488	0.000569	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CCR5—epilepsy syndrome	0.000482	0.000561	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—HTR2A—epilepsy syndrome	0.000472	0.000549	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	0.000455	0.00053	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—TSC1—epilepsy syndrome	0.000454	0.000529	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—PTK2B—epilepsy syndrome	0.000454	0.000529	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—AGT—epilepsy syndrome	0.000447	0.000521	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—SST—epilepsy syndrome	0.000442	0.000515	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CCR2—epilepsy syndrome	0.000442	0.000515	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—NTRK2—epilepsy syndrome	0.000442	0.000515	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—DUSP6—epilepsy syndrome	0.000438	0.00051	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000432	0.000504	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—PLAT—epilepsy syndrome	0.00043	0.000502	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CXCL12—epilepsy syndrome	0.000415	0.000484	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000415	0.000484	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—POMC—epilepsy syndrome	0.000415	0.000483	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—PRKCB—epilepsy syndrome	0.000413	0.000482	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—IL6ST—epilepsy syndrome	0.000412	0.00048	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—JUNB—epilepsy syndrome	0.000408	0.000475	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CNR1—epilepsy syndrome	0.000408	0.000475	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—PLCB1—epilepsy syndrome	0.000406	0.000473	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—HTR7—epilepsy syndrome	0.000398	0.000463	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—HBEGF—epilepsy syndrome	0.000386	0.00045	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—AKT3—epilepsy syndrome	0.000379	0.000442	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—POMC—epilepsy syndrome	0.000377	0.000439	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—ADAM10—epilepsy syndrome	0.00037	0.000431	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—CCL2—epilepsy syndrome	0.000368	0.000429	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—S100B—epilepsy syndrome	0.00035	0.000408	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	0.000347	0.000404	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	0.000346	0.000403	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	0.000335	0.00039	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	0.000317	0.000369	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	0.000308	0.000359	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	0.000307	0.000357	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	0.000306	0.000357	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	0.000296	0.000345	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	0.000293	0.000341	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	0.000285	0.000332	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	0.000279	0.000325	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	0.000265	0.000308	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	0.000264	0.000308	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	0.000259	0.000302	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	0.000254	0.000296	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	0.000244	0.000285	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	0.000243	0.000283	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	0.000222	0.000259	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	0.000218	0.000254	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	0.000197	0.000229	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	0.000183	0.000213	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	0.000179	0.000209	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	0.000166	0.000194	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	0.000165	0.000192	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	0.00016	0.000186	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	0.000156	0.000181	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	0.000151	0.000176	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	0.000143	0.000167	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	0.00014	0.000163	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	8.92e-05	0.000104	CbGpPWpGaD
